Conditions:   Squamous Cell Carcinoma;   Laryngeal Cancer
Intervention:  
Sponsors:   Masonic Cancer Center, University of Minnesota;   American Academy of Otolaryngology-Head and Neck Surgery Foundation;   American Head and Neck Society
Recruiting - verified March 2010

Condition:   HIV
Interventions:   Drug: Efavirenz;   Drug: Over-encapsulated efavirenz
Sponsor:   University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified March 2010

Condition:   Type 2 Diabetes
Intervention:   Drug: Exenatide, Insulin Glargine or Exenatide + Insulin Glargine
Sponsors:   Park Nicollet Institute;   International Diabetes Center at Park Nicollet;   Sanofi-Aventis
Not yet recruiting - verified March 2010

Conditions:   Obesity;   Injury
Interventions:   Behavioral: Healthy Eating/Physical Activity;   Behavioral: Safety/Injury Prevention
Sponsors:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Washington;   University of Minnesota School of Public Health
Not yet recruiting - verified March 2010

Condition:   Primary Sclerosing Cholangitis
Interventions:   Drug: Vancomycin;   Drug: Vancomycin;   Drug: Metronidazole;   Drug: Metronidazole;   Drug: Vancomycin
Sponsors:   Mayo Clinic;   PSC Partners Seeking a Cure Foundation
Recruiting - verified March 2010

Condition:   Pregnant Women With Peripartum Cardiomyopathy
Intervention:  
Sponsors:   University of Pittsburgh;   National Institutes of Health (NIH)
Recruiting - verified March 2010

Condition:   Inguinal Hernia
Intervention:   Behavioral: Mastery Learning TEP Curriculum
Sponsors:   Mayo Clinic;   National Center for Research Resources (NCRR)
Recruiting - verified March 2010

Condition:   Barrett's Esophagus
Intervention:  
Sponsor:   Mayo Clinic
Enrolling by invitation - verified March 2010

Conditions:   Mild Cognitive Impairment;   Alzheimer's Disease
Intervention:  
Sponsors:   Alzheimer's Disease Cooperative Study (ADCS);   National Institute on Aging (NIA);   National Institutes of Health (NIH)
Not yet recruiting - verified March 2010

Condition:   Obesity
Interventions:   Behavioral: Busy Bodies/Better Bites;   Behavioral: Healthy Spots/Safe Tots
Sponsors:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010

Condition:   Healthy Volunteers
Interventions:   Dietary Supplement: Single High Dose Cholecalciferol;   Dietary Supplement: Daily Dose Cholecalciferol
Sponsor:   Mayo Clinic
Recruiting - verified March 2010

Condition:   Peptic Ulcer
Intervention:   Device: Endoscopic Translumenal Omental Patch
Sponsor:   Mayo Clinic
Not yet recruiting - verified March 2010

Conditions:   Cryptococcal Meningitis;   HIV Infections;   AIDS
Interventions:   Other: Early HIV Therapy Initiation;   Other: Standard HIV Therapy Initiation
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   Makerere University;   Mbarara University of Science and Technology;   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010

Condition:   Acute Coronary Syndrome
Interventions:   Other: Decision Aid;   Other: Usual care
Sponsor:   Mayo Clinic
Enrolling by invitation - verified February 2010

Conditions:   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Peripheral T-Cell Lymphoma;   Post-transplant Lymphoproliferative Disorder;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Splenic Marginal Zone Lymphoma;   Waldenstrom Macroglobulinemia
Interventions:   Drug: everolimus;   Drug: lenalidomide;   Other: laboratory biomarker analysis;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Genetic: microarray analysis;   Genetic: fluorescence in situ hybridization
Sponsor:   Mayo Clinic
Not yet recruiting - verified February 2010

Condition:   Breast Cancer
Intervention:  
Sponsor:   Park Nicollet Institute
Recruiting - verified February 2010

Condition:   Hepatitis C Recurrence
Intervention:   Drug: Nitazoxanide
Sponsor:   Mayo Clinic
Recruiting - verified February 2010

Condition:   Diabetes Mellitus
Interventions:   Device: Finesse;   Device: Pen/Syringe (Usual injection device)
Sponsors:   Calibra Medical, Inc.;   Nancy Bohannon, MD, Med. Corp.;   Henry Ford Health System;   Northwestern University;   University of Texas Southwestern Medical Center;   Joslin Diabetes Center;   International Diabetes Center at Park Nicollet
Recruiting - verified March 2010

Condition:   Type 2 Diabetes
Interventions:   Other: SMBG to guide clinical decisions;   Other: SMBG and CGM
Sponsors:   Park Nicollet Institute;   International Diabetes Center at Park Nicollet;   Abbott Diabetes Care
Recruiting - verified February 2010

Condition:   Primary Systemic Amyloidosis
Interventions:   Drug: bortezomib;   Drug: cyclophosphamide;   Drug: dexamethasone
Sponsor:   Mayo Clinic
Not yet recruiting - verified February 2010

Condition:   Acute Renal Failure
Intervention:   Device: Selective cytopheretic device (SCD)
Sponsors:   CytoPherx, Inc;   Harvard Clinical Research Institute;   Medtox
Recruiting - verified February 2010